Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma Adam J. BogradKei SuzukiPrasad S. Adusumilli Review 13 September 2011 Pages: 1509 - 1527
Dual biological effects of the cytokines interleukin-10 and interferon-γ Cailin Moira WilkeShuang WeiWeiping Zou Opinion Paper 15 September 2011 Pages: 1529 - 1541
Priming with very low-affinity peptide ligands gives rise to CD8+ T-cell effectors with enhanced function but with greater susceptibility to transforming growth factor (TGF)β-mediated suppression Jeremy A. O’SullivanAndrew ZlozaJosé A. Guevara-Patiño Original article 17 June 2011 Pages: 1543 - 1551
Vaccination of patients with cutaneous melanoma with telomerase-specific peptides Robert E. HungerKristin Kernland LangGustav Gaudernack Original article 17 June 2011 Pages: 1553 - 1564
Comprehensive immunological analyses of colorectal cancer patients in the phase I/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide Mitsuru SakakibaraTatsuya KantoNorio Hayashi Original article 17 June 2011 Pages: 1565 - 1575
Prostaglandin E2 (PGE2) suppresses natural killer cell function primarily through the PGE2 receptor EP4 Dawn HoltXinrong MaAmy Fulton Original article 17 June 2011 Pages: 1577 - 1586
Increased prevalence of regulatory T cells in the lung cancer microenvironment: a role of thymic stromal lymphopoietin Hui LiHua ZhaoXiubao Ren Original Article 17 June 2011 Pages: 1587 - 1596
Vaccination with CD133+ melanoma induces specific Th17 and Th1 cell–mediated antitumor reactivity against parental tumor Takao MiyabayashiHiroshi KagamuIchiei Narita Original Article 21 June 2011 Pages: 1597 - 1608
Poly(I:C)-induced tumour cell death leads to DC maturation and Th1 activation Edit KovalcsikKatie LoweMark D. Bodman-Smith Original article 21 June 2011 Pages: 1609 - 1624
Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™ Theo NicholaouWeisan ChenJonathan Cebon Original article 23 June 2011 Pages: 1625 - 1637
Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transfer Riccardo TurriniAnna MerloAntonio Rosato Short communication Open access 11 August 2011 Pages: 1639 - 1645
“Tumor immunology meets oncology (TIMO) VII” from 15th to 16th of April 2011 in Halle/Saale, Germany Juergen BukurElfriede NoessnerBarbara Seliger Meeting report 11 September 2011 Pages: 1647 - 1653